Showing results (961-970 of 3,497) with videos related to

Sort By:
Pageof 350
Eclinicalmedicine|June 24, 2022
Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumoursDaniel D Karp, D Ross Camidge, Jeffery R Infante, et al.
Eclinicalmedicine|June 24, 2022
Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomesLei Xia, Zi-Yun Qiao, Zi-Jie Zhang, et al.
Eclinicalmedicine|June 24, 2022
Clinical presentation and short-term outcomes of multisystemic inflammatory syndrome in children in Lagos, Nigeria during the COVID-19 pandemic: A case seriesOgochukwu Sokunbi, Yeside Akinbolagbe, Patricia Akintan, et al.
Eclinicalmedicine|June 20, 2022
Area-level socioeconomic deprivation, non-national residency, and Covid-19 incidence: A longitudinal spatiotemporal analysis in GermanySven Rohleder, Dr Diogo Costa, Prof Kayvan Bozorgmehr
Eclinicalmedicine|June 15, 2022
A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort studyZiyue Wang, Adam Cryar, Oliver Lemke, et al.
Eclinicalmedicine|June 16, 2022
Effects of intranasal (S)-ketamine on Veterans with co-morbid treatment-resistant depression and PTSD: A retrospective case seriesHewa Artin, Sean Bentley, Eamonn Mehaffey, et al.
Eclinicalmedicine|June 16, 2022
Body-mass index trajectories from childhood to mid-adulthood and their sociodemographic predictors: Evidence from the International Childhood Cardiovascular Cohort (i3C) ConsortiumVerity Cleland, Jing Tian, Marie-Jeanne Buscot, et al.
Eclinicalmedicine|June 16, 2022
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trialDean A Fennell, Catharine Porter, Jason Lester, et al.
Eclinicalmedicine|June 16, 2022
Influence and effects of weight stigmatisation in media: A systematicJames Kite, Bo-Huei Huang, Yvonne Laird, et al.
Eclinicalmedicine|June 16, 2022
Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databasesJingjing Wang, Xin Zhang, Xiaozhen Geng, et al.
Pageof 350